UNIGEN
Ikeda, Gifu, Japan
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: UNIGEN
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Ikeda, Gifu, Japan
- Website
- https://www.unigen-bio.com/
- Modalities
- Biologics, Vaccines
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About UNIGEN
UNIGEN is a contract development and manufacturing organization (CDMO). Capabilities: Biologics, Vaccines. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.unigen-bio.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Frequently Asked Questions About UNIGEN
Does UNIGEN have a CDMO Signal Score?
Not yet. UNIGEN is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating UNIGEN for a manufacturing program?
Use the free AI matchmaker to compare UNIGEN against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
MicroBiopharm Japan
Tokyo, Japan
Microbial Fermentation, High-Potency APIs, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 87.7
Biologics, mRNA
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 84.8
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Piramal Pharma Solutions
Lexington, KY · Riverview, MI · Ahmedabad, IN
Signal Score: 83.5
Biologics, ADC
Compare UNIGEN with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.